Deleveraging Stocks
Entities in this cohort prioritize debt reduction and balance sheet fortification to lower interest expense and improve credit ratings during periods of high leverage or cyclical volatility. Capital allocation strategies shift away from aggressive growth or shareholder returns toward principal repayment, asset divestitures, and free cash flow optimization to mitigate insolvency risks.
As of Oct 23, 2026, Deleveraging has 19 US-listed companies worth $230B combined. The median member moved +0.4% over the past week; TU led at +4.6% and QVCG trailed at -12.4%.
Companies in Deleveraging
- WBD – Warner Bros Discovery Inc, $77.6B
- CVE – Cenovus Energy Inc, $60.6B
- TEVA – Teva Pharma Industries Ltd ADR, $46B
- TU – Telus Corp, $13.3B
- HLI – Houlihan Lokey Inc, $9.2B
- RYN – Rayonier Inc, $5.7B
- TDS – Telephone and Data Systems Inc, $3.9B
- BTE – Baytex Energy Corp, $3.8B
- DAN – Dana Inc, $3.1B
- BHC – Bausch Health Companies Inc, $2.4B
- NRP – Natural Resource Partners LP, $1.4B
- NBR – Nabors Industries Ltd., $1.2B
- LOGC – Contextlogic Inc, $691M
- QVCG – QVC Group, Inc. Common Stock, $643M
- NCMI – National CineMedia Inc, $199M
- CMTG – Claros Mortgage Trust Inc, $174M
- SRG – Seritage Growth Properties, $91.2M
- ACH – Accendra Health Inc, $19.6M
- TPHS – Trinity Place Holdings Inc, $2M